"Designing Growth Strategies is in our DNA"

U.S. Blood Transfusion Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Product (Instruments and Reagents & Kits), By Application (Blood Screening, Blood Group Typing) and By End-user (Hospital-based Laboratories and Independent Laboratories & Blood Banks), 2022-2029

Last Updated: July 01, 2024 | Format: PDF | Report ID: FBI107024

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The U.S. blood transfusion diagnostics market size was valued at USD 1.91 billion in 2021 and is projected to grow from USD 2.20 billion in 2022 to USD 3.58 billion by 2029, at a CAGR of 7.2% during the forecast period. The global market exhibited a decline of -6.5% in 2020 as compared to 2019. The global COVID-19 pandemic has been unprecedented and staggering, with blood transfusion diagnostics experiencing lower-than-anticipated demand in the U.S. compared to pre-pandemic levels.


Blood transfusion diagnostics refer to the tests performed on blood or blood components prior to the transfusion process. These tests are referred to as pre-transfusion tests such as blood group typing and blood screening which are imperative as they help in avoiding adverse reactions or prevent the transmission of any infection. They also aid healthcare professionals in finding compatibility between the donor's and the recipient’s blood types. Furthermore, there is increased adoption of these products in blood banks where several tests are performed or store donated blood units and later conduct a safe transfusion process. Thus, these factors have also accelerated the demand as these diagnostics refer to tests, which are mandatory for the blood transfusion process in the country.


Over the recent years, growth in the number of blood transfusions due to a number of factors has been witnessed. This is due to the surge in the launches of new products to cater to the needs of patients requiring regular blood transfusions. Furthermore, due to the increasing number of blood donations in the country, blood group typing and screening procedures are performed more frequently, which will help the market to record strong growth in the forecast period. The awareness regarding blood transfusion diagnostics procedures among the population and the growing demand for blood and blood components are expected to contribute positively to the transfusion diagnostics market growth in the forecast period.  


COVID-19 IMPACT


Global Market Witnessed a Negative Impact due to Decline in Blood Transfusion Procedures


The impact of COVID-19 on the U.S. healthcare system differed as the impact varied from market to market. Preventative steps such as lockdowns imposed by the regulatory bodies to curb the spread of the virus led to the decline of the blood transfusion diagnostics market.


The decline in the number of patients visiting healthcare institutions led to a considerable drop in the number of blood transfusion diagnostic procedures as it refers to tests performed as a prerequisite for surgical and transplantation procedures. Furthermore, a decline in the number of blood donations led to a limited number of blood group typing and screening procedures. Thus, both of these factors led to the decline of the market.



  • For instance, in January 2022, the American Red Cross Society mentioned that it was responsible for the provision of 40.0% of the blood units used in the U.S. However, post the pandemic, there was a shortage of blood donations which led to a decline of 10.0% in the total number of people donating blood. Furthermore, owing to the shortage, the organization had to limit the distribution of blood to hospitals.


Major companies with significant product applications and portfolios for transfusion diagnostics also reported a decline in their revenue as the demand for their products declined during the pandemic. Disruption in their manufacturing and supply chain operations also leads to a decline in their revenue.



  • For example, Bio-Rad Laboratories, Inc. witnessed a decline of 7.6% in its clinical diagnostics segments during FY 2020 compared to the same period in 2019. The company’s transfusion diagnostics portfolio falls under its clinical diagnostics segment.


In 2021, after the COVID-19 restrictions were lifted, the market witnessed growth as healthcare activities returned to their normal pace. Furthermore, the rise in organ transplants, a key procedure that requires blood transfusions, also increased, which contributed to the market growth. 



  • For instance, the data provided by the United Network of Organ Sharing (UNOS) states that a total of 41,354 organ transplant surgeries were performed in 2021 in the U.S., leading to an increase of 5.9% as compared to 2020.


Therefore, key players also reported an increase in their revenue as compared to the previous year due to the increase in the number of blood transfusion diagnostics procedures in 2021.



  • For example, Abbott witnessed an increase of 14.6% in the revenue generated by their core laboratories segment in 2021 as compared to the previous year. The company’s transfusion diagnostics portfolio falls under its core laboratories segment.


LATEST TRENDS


U.S. Blood Transfusion Diagnostics Market Size


Adoption of Automated Blood Group Typing Technologies to Drive Market Growth


The increasing focus of major players toward launching automated blood group typing technologies can be considered one of the major trends in the market. Automated technologies improve the diagnostic transfusion process by reducing the turnaround time without compromising safety and maintaining the standard. The automated platforms have proven to be pivotal for the detection of transfusion-transmitted infections (TTIs) in an individual’s blood sample eliminating human error during the transfusion process.


The technology is said to significantly improve the diagnostic transfusion process by enhancing its speed and maintaining standardization along with safety. Automated blood group typing solutions provide several benefits such as efficiency, cost-effectiveness, and few errors compared to manual typing systems. Furthermore, automated blood group typing solutions do not require multiple healthcare personnel, which can lead to cross-trained and less experienced medical professionals in transfusion service.



  • In July 2022, Rhinostics announced the launch of an automated sample collection technology with the launch of a patent-pending VERIstic collection device that focuses on a small volume of blood collection.


Therefore, the launch of such advanced technologies is expected to fuel market growth in the forecast period.  


DRIVING FACTORS


Rising Demand for Blood and Blood Components to Accelerate Market Growth 


The growing prevalence of blood-related disorders, such as hemophilia, leukemia, and thrombocytopenia, and the rapid increase in chronic diseases amongst the general population have been responsible for the increased demand for transfusion of blood and blood components.



  • For example, according to the data published by the Leukemia & Lymphoma Society, it was estimated that around 376,508 people in the U.S. were living with or in remission from leukemia in 2020.


Furthermore, rising cases of blood disorders amongst geriatric patients suffering from blood disorders also lead to an increase in the demand for blood transfusion diagnostics. Similarly, growth in the number of patients suffering from anemia has also led to an upsurge in demand for blood transfusion diagnostics procedures in the country. This, along with the increasing number of surgical procedures due to the rising number of trauma cases and road accidents, further augments the demand for blood transfusion procedures. Therefore, the above factors are contributing to the increasing demand for these diagnostics and are thus fueling the growth of the market in the forecast period.


Increase in Number of Blood Donations to Propel Market Growth


The country witnessed a rise in the number of blood donations over a decade. The surge in the adoption of blood group typing and blood screening procedures during these blood donation procedures has fueled the growth of the market.


The COVID-19 pandemic drastically led to a decrease in the number of blood donations during that time period. However, the growing demand for blood in the country for several surgical and medical applications will eventually lead to an increase in the number of donations.



  • For instance, in September 2021, the American Red Cross mentioned that sickle cell disease affects 90,000 to 100,000 people in the U.S., and these patients require blood transfusion throughout their lives, therefore increasing the need for blood donations. 


Similarly, several government initiatives in regard to voluntary blood donations are also anticipated to accelerate the growth in the number of donations in the forecast period.



  • For instance, in August 2022, the U.S. Department of Health and Human Services (HHS) announced a new campaign to increase blood and plasma donations known as “Giving=Living.”


Hence, the growth in the number of blood donations in the country will lead to the increasing adoption of these products in several facilities, including hospitals and blood donation centers thereby, leading to market growth in the forecast period of 2022-2029.


RESTRAINING FACTORS


Adverse Reactions Associated with Blood Transfusion Processes May Hinder Market Growth Prospects


Blood transfusions may sometimes cause side effects, including allergic reactions, blood-borne infections, and fever or acute hemolytic reactions. These side effects associated with transfusion procedures may negatively affect the growth of the market in the forecast period.



  • For example, according to a report published in eClinicalMedicine in May 2020, a study was conducted in the U.S. to assess transfusion reactions in pediatric and adolescent young adults in hematology and immune effector cell patients.


Another adverse reaction an individual faces during a transfusion process is an acute immune hemolytic reaction. It is a rare reaction but is considered serious and is caused when a patient’s blood does not match with the donor. The reaction is caused when the transfused red blood cells are destroyed by the patient’s immune system, causing hemolysis.



  • According to the American Red Cross, blood-borne infections from blood transfusions are rare; however, there are slight chances for them to occur.


Such side effects associated with blood transfusion procedures may negatively impact its adoption amongst patients opting for it. This may hinder the U.S. blood transfusion diagnostics market growth.  


SEGMENTATION


By Product Analysis


Significant Product Launches in Reagents & Kits Lead to the Segment’s Dominance


On the basis of product, the market is bifurcated into reagents & kits and instruments. The reagents & kits segment holds a dominant share of the market. The segment dominates the blood transfusion diagnostics market as these products are used more often compared to the instruments. Furthermore, initiatives by key companies to launch new products in this segment also lead to its dominance.



  • For instance, in July 2022, Immucor, Inc. announced that they received FDA approval for a blood grouping reagent, nti-Jka (Monoclonal), Anti-Jkb (Monoclonal) Gamma-clone, Anti-S, Anti-s and Anti-Fya (IgG)


The instruments segment holds a comparatively lower U.S. blood transfusion diagnostics market share as the cost associated with these products are much higher. Furthermore, the instruments have a longer shelf life, and thus the replacement rate is lower as compared to reagents & kits. Moreover, a single instrument can be used for multiple purposes, which leads to slower adoption of these products.



  • For instance, in July 2020, Beckman Coulter, Inc. received FDA approval for its PK7400 Automated Microplated System along with the instrument’s reagents.


By Application Analysis


To know how our report can help streamline your business, Speak to Analyst


Blood Screening Segment to Grow at a Moderately Faster Pace due to the Prevalence of Transfusion-Transmissible Infections


Based on application, the market is segmented into blood group typing and blood screening. The blood screening segment is expected to record a comparatively higher CAGR over the forecast period. This is due to the growing prevalence of transfusion-transmissible infections along with the presence of a vast product portfolio to cater to the growing number of blood screening procedures.



  • For instance, in May 2020, Grifols, S.A. announced that the U.S. FDA approved Procleix Panther System featuring ART to be used with the U.S. licensed products: Procleix Ultrio Elite Assay, Procleix WNV Assay, Procleix Zika Virus Assay, and the Procleix Babesia Assay.


The blood group typing segment is estimated to grow at a comparatively lower CAGR in the forecast period. However, the growing demand for pre-transfusion blood group typing tests to check for the compatibility of the donor and the recipient blood type will lead to the segment’s growth in the forecast period.


By End-user Analysis


Strong Patient Volumes in Blood Banks & Independent Laboratories Ensured Segment’s Dominance in 2021


Based on end-user, the market is divided into independent laboratories & blood banks and hospital-based laboratories. The independent laboratories & blood banks segment is likely to account for the highest market share during the forecast period. This segment's dominance is owing to the growing number of labs and stand-alone clinical laboratories. Furthermore, partnerships amongst labs and government organizations such as the American Red Cross are also expected to fuel the growth of the segment in the forecast period.



  • For instance, according to the Blood Centers of America (BCA), over 60 independent community blood collection centers collect and distribute 50% of the country’s blood supply.


The presence of a large number of hospitals with laboratories having advanced instruments to perform blood transfusions in the U.S. resulted in the growth of the hospital-based laboratories segment.



  • For instance, according to the statistics published by the American Hospital Association, in 2022, the total number of hospitals in the U.S. were estimated to be 6,093.


KEY INDUSTRY PLAYERS


Strong Product Portfolio and Significant Regulatory Approvals to Enable Grifols, S.A. and F. Hoffmann-La Roche Ltd. Led to Market Dominance in 2021


In terms of the competitive landscape, the market reflects the presence of established companies. Grifols, S.A. dominated the U.S. market in 2021. The company's apex position is attributed to the presence of versatile blood transfusion diagnostics products in the U.S.



  • For instance, in March 2021, Grifols, S.A. installed the DG Reader Net semi-automated analyzer to facilitate pre-transfusion blood type compatibility testing in North America.


Other prominent companies with a considerable presence in the market include F. Hoffmann-La Roche Ltd and QuidelOrtho Corporation. Multiple regulatory approvals received by these companies have contributed to the dominance of these companies' market share.



  • In September 2020, F. Hoffmann-La Roche Ltd. announced that they received FDA approval for the cobas HIV-1/HIV-2 qualitative test to be used in their fully automated cobas 6800/8800 systems.


Such major factors are expected to further enable these companies to strengthen their market presence. Other players, such as Bio-Rad Laboratories, Abbott, Quotient Limited, Beckman Coulter, Inc., and Immucor, Inc., with their strong distribution network and diverse product portfolio are steadily increasing their presence in the market.


LIST OF KEY COMPANIES PROFILED:



KEY INDUSTRY DEVELOPMENTS:



  • June 2022: Alba Bioscience Limited (QUOTIENT LIMITED) announced that they received the USFDA approval for ORTHO Sera and ALBAclone blood grouping reagents.

  • June 2022: Ortho-Clinical Diagnostics, Inc. announced that they received the 510(k) approval from the USFDA to launch ORTHO Optix Reader for blood group typing solutions.

  • January 2021: Grifols, S.A. received approval from the USFDA for the launch of DG Gel Card Blood Grouping Reagent Combination Kit for blood group typing prior to transfusion.

  • February 2021: F. Hoffmann-La Roche Ltd announced that they received the USFDA approval for cobas MPX to be used as a multiplex HIV, HCV, and NBV nucleic acid test in human serum and plasma.

  • October 2020: Calibre Scientific acquired Lorne Laboratories, which manufactures diagnostic test kits and blood grouping reagents for medical procedures.


REPORT COVERAGE


An Infographic Representation of U.S. Blood Transfusion Diagnostics Market

To get information on various segments, share your queries with us



The U.S. blood transfusion diagnostics market research report provides a detailed analysis and factors driving the market. It focuses on key aspects such as an overview of technological advancements, prevalence of key bleeding disorders, and blood donation statistics. Additionally, the report includes an insight regarding blood donations and blood group type, distribution of blood group type in the population, blood transfusion statistics, new product launches, key industry developments, such as mergers, partnerships, & acquisitions, and the impact of COVID-19 on the market. Besides this, the report also offers insights into the market trends and highlights key industry dynamics. In addition to the aforementioned factors, it encompasses several factors that have contributed to the growth of the market in recent years.


Report Scope & Segmentation


















































  ATTRIBUTE



  DETAILS



Study Period



2018-2029



Base Year



2021



Estimated Year



2022



Forecast Period



2022-2029



Historical Period



2018-2020



Unit



Value (USD billion)



Segmentation



By Product, Application, End-user



By Product




  • Instruments

  • Reagents & Kits



By Application


 




  • Blood Screening

  • Blood Group Typing



By End-user




  • Hospital-based Laboratories

  • Independent Laboratories & Blood Banks






Frequently Asked Questions

Fortune Business Insights says that the market size was USD 1.91 billion in 2021 and is projected to reach USD 3.58 billion by 2029.

Registering a CAGR of 7.2%, the market will exhibit steady growth during the forecast period (2022-2029).

The blood screening segment is expected to lead this market during the forecast period.

The increasing demand for blood and blood components, technological advancements, and the high prevalence of blood disorders are driving the growth of the market.

Grifols, S.A., F. Hoffmann-La Roche Ltd, and QuidelOrtho Corporation are the top players in this market.

Increased number of blood donations, which leads to adoption of transfusion diagnostics products and new launches of advanced products and applications are expected to drive the adoption.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • 2018-2029
  • 2021
  • 2018-2020
  • 106

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X